Repair Biotechnologies, Inc. is a biotechnology company with the mission to develop and bring to the clinic therapies that significantly improve human healthspan through targeting the causes of age-related diseases and aging itself. Founded in 2018, Repair Biotechnologies is developing therapies with the goals of regenerating the thymus, treating cancer, and reversing atherosclerosis.
Market
Healthspan improvement and age-related disease therapies
Location
Syracuse,
NY,
USA
Coinvestors
Emerging Longevity Ventures, Jim Mellon, SENS Research Foundation, Thynk Capital